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a  b  s  t  r  a  c  t
The  present  study  is  aimed  to  enhance  the oral  bioavailability  of  ketoprofen  by  inserting  it into  the  matrix
of poly(vinylpyrrolidone)  (PVP)  K10  spatially  conﬁned  into  microcontainers,  by means  of supercritical
CO2-aided  impregnation.  Microcontainers  are  cylindrical  reservoirs,  with  typical  sizes  in  the  micrometer
range,  with  a  cavity  open  on  one  side,  where  the  drug  formulation  is  loaded.  Differently  to  traditional
tablets,  microcontainers  have  a higher  surface  area  per unit  volume,  and  release  the  drug  only  in one
direction.  This  design  is  meant  to enhance  the absorption  of problematic  drugs,  like those  with  poor  sol-
ubility in  water.  In a previous  study  we introduced  a  novel  technique  for  drug  loading  of  microcontainers,
based  on inkjet  printing  and  supercritical  impregnation  (SCI).  We  showed  that  SCI  produces  accurate  and
reproducible  drug  loading  for large  arrays  of  microcontainers.  In  the  attempt  of enhancing  the throughput
of  the  loading  methods,  we  propose  the  replacement  of  polymer  inkjet  printing  with  an  easier  man-
ual  compression  of  the  PVP  powder  into  the  microcontainers.  As the  second  step,  the  polymer  powder
ﬁlled-microcontainers  were  submitted  to  SCI.  The  separate  role  of different  impregnation  parameters
(temperature,  pressure,  time,  drug  concentration  in  the  supercritical  phase)  was elucidated  with  respect
to the loading  capacity.  The  microcontainer  ﬁlling  was  observed  by means  of optical  macroimaging,  X-
ray  microtomography  and  scanning  electron  microscopy.  The  physical  state  of  the  drug  was  investigated
by  means  of Raman  spectroscopy  and compared  with  selected  representative  PVP-ketoprofen  physical
mixtures.  Finally,  the  drug  loading  was  estimated  by means  of  in  vitro  dissolution  tests.
The  characterization  study  shows  that  the  present  loading  method  is  a valuable  alternative  to the one
previously  described.  The  drug  loading  can  be controlled  with  high  accuracy  and  reproducibility  and
the impregnated  drug  is  in amorphous  state. These  results  demonstrate  that  SCI  can  be  used  as  a high
throughput  loading  technique  for  microfabricated  devices  for oral  drug  delivery.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Among the different drug delivery routes oral administration
is still the most preferred one for its simplicity, minimal inva-
siveness, and high patient compliance. Nevertheless, the human
digestive system presents a sequence of physiological barriers
which drastically reduce the bioavailability of many active phar-
maceutical ingredients (API): enzymatic degradation, hydrolysis
∗ Corresponding author.
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in the gastric acidic environment, thick mucus layer covering the
intestinal mucosa, selective transport action of peptide receptors
in the epithelial cells [1]. In particular, oral delivery of APIs that
exhibit either low solubility in water or low permeability through
biological membranes or both is challenging. The solid state prop-
erties of drugs have a strong inﬂuence on their solubility. Whilst
amorphous drug candidates exhibit an enhanced solubility and
dissolution rate compared to their crystalline counterparts, amor-
phous forms often suffer from rather short thermodynamic stability
and they spontaneously tend to crystallize [2]. As a result, sta-
bilization of amorphous forms is necessary in order to preserve
the above-mentioned advantages [3]. Physical stabilization of the
http://dx.doi.org/10.1016/j.supﬂu.2015.08.023
0896-8446/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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amorphous form can be achieved by the addition of a polymeric
carrier wherein the drug is conﬁned in supramolecular domains
or even molecularly dispersed [4]. Together with the solid state
properties, the solubility and dissolution rate can be improved by
reducing the particle size of the formulation [5]. Among the several
formulation approaches [6] supercritical ﬂuid based technology
is a promising technique to produce micro- and nanoparticulate
systems with high drug dispersion and enhanced stability and dis-
solution properties [7].
Besides the properties of the drug formulation, an important role
in the therapeutic performance is often played by the design of the
administration form. Conventional oral dosage forms like tablets
provide an omni-directional drug release through their limited
interfacial area when exposed to the physiological ﬂuids. Further-
more, drug release from tablets is often slow compared to the
peristaltic ﬂow in the small intestine, where the most permeable
tissue for drug absorption is located. As a result, a large amount
of API is not delivered, and patients need to ingest multiple drug
doses to receive the desired therapeutic beneﬁt. This increases the
occurrence of potentially harmful side effects in patients [8].
In the last 10 years advances in ﬁeld of micro- and nanofabri-
cation have allowed the development of alternative drug delivery
systems [9]. In particular there has been an increasing interest in
microfabricated devices based on the concept of microcontainers
[10]. A microcontainer is a reservoir with the typical dimensions
falling in the micrometer range, composed of a non-permeable
and inert shell and a cavity for the drug formulation open on one
side from which the drug is released unidirectionally. The size
of these microcontainers are chosen to allow an enhanced inti-
mate contact with the irregular surface of the mucosa with respect
to other macroscopic drug delivery systems and to avoid typical
issues of smaller micro- and nano-sized systems like clustering,
physical stability and unspeciﬁc endocytosis. Several groups devel-
oped microcontainers in different shapes, materials and designs,
where fabrication is typically performed on ﬂat silicon substrates.
By virtue of its asymmetric shape and by applying appropri-
ate bioadhesive coatings on microcontainers Ainslie et al. [11]
showed an increased intestinal retention time for these microde-
vices and an enhanced bioavailability for a model poorly water
soluble drug. One of the largest challenges in the fabrication of
microcontainers concerns the drug loading step. In a previous work
[12], we showed the fabrication of cylindrical microcontainers,
fabricated with the epoxy resin SU-8. The microwells were ﬁlled
with poly(vinylpyrrolidone) (PVP) by inkjet printing. This method
showed high accuracy and a minimal waste of materials. In a more
recent work [13] we proposed the combination of inkjet prin-
ting and supercritical technology to impregnate the polymer-ﬁlled
microcontainers with ketoprofen, a poorly water soluble drug. We
demonstrated that the supercritical impregnation technique allows
a highly accurate and reproducible drug loading of large arrays of
microcontainers. In an attempt to enhance the throughput of this
loading method, we propose a simpliﬁed variant of our previous
work. Here the polymer printing was replaced by an easier ﬁlling
method, consisting of a manual compression of the polymer pow-
der into the microcontainer. Later, the powder ﬁlled-containers
were submitted to supercritical impregnation (SCI) as previously
described [13]. This process modiﬁcation enabled a signiﬁcant
reduction in the sample preparation time and made it possible to
investigate the effect of temperature, pressure and impregnation
times on different aspects concerning the drug loading in more
detail.
The loading procedure was characterized with different tech-
niques. X-ray microtomography was used to measure the level
of ﬁlling and the morphology of the polymer powder in the
microreservoir cavities before and after the SCI. In addition, micro-
containers were visualized by scanning electron microscopy (SEM)
Fig. 1. Chemical structure of (a) ketoprofen, (b) monomer of poly(vinyl pyrrolidone)
(PVP).
to observe the effect of the impregnation parameters on the poly-
mer  morphology. Raman spectroscopy was used to investigate the
drug solid state in the impregnated matrices and drug-polymer
interactions. Finally, in vitro dissolution tests were carried out and
the total drug loading was estimated. The results showed that
the replacement of inkjet printing with the powder ﬁlling method
enhances the throughput of the microcontainer loading technique
without compromising the accuracy or the reproducibility of the
whole loading process.
2. Materials and methods
2.1. Fabrication of SU-8 microcontainers
2.1.1. Materials and fabrication of microcontainers
Silicon wafers (4-in. b100N n-type) were supplied by Okmetic
(Vantaa, Finland). SU-8 2075 and SU-8 developer were purchased
from Microresist Technology GmbH (Berlin, Germany).
Cylindrical microcontainers were fabricated with a similar
procedure as previously described [12]. The microwells were fab-
ricated with the epoxy-based photoresist SU-8 on silicon wafers. A
microcontainer has a cavity of approximately 300 m in diameter
and 250 m in depth and an approximated volume of 18 nL. After
the fabrication the wafer was  cut into square chips containing 625
microcontainers (DISCO DAD 321, Automatic Dicing Saw).
2.2. Drug loading of microcontainers
2.2.1. Materials
Ketoprofen (98%, racemate) and poly(vinylpyrrolidone) (PVP
K10, Mw 10,000) were supplied by Sigma Aldrich. In Fig. 1 the
molecular structures of the compounds are shown. Carbon diox-
ide was supplied by SIAD (99% purity). Ketoprofen is a nonsteroidal
anti-inﬂammatory drug (NSAID) with analgesic and antipyretic
properties. In several pharmacopeias ketoprofen is considered as
practically insoluble in water [14,15]. The solubility of the crys-
talline form of ketoprofen in pure water at room temperature
(22–24 ◦C) was  reported to be 0.010 mg/mL [15]. Thus, ketoprofen
is classiﬁed as a class II active principle in the biopharmaceutical
classiﬁcation system (BCS): It exhibits low aqueous solubility and
a high intestinal permeability.
2.2.2. Filling with poly(vinylpyrrolidone) PVP powder
Microcontainers were ﬁlled with PVP powder with the following
procedure: The powder was  deposited and compacted with a spat-
ula onto the microwells and the residual amount, placed in between
containers, was  blown away by means of pressurized air. The chip
was weighed before and after ﬁlling and the average PVP weight per
chip was 1.93 ± 0.08 mg  (calculated from 35 samples). The level of
microcontainer ﬁlling was  measured by X-ray microtomography at
different positions on the chip.
2.2.3. Supercritical impregnation of polymer
ﬁlled-microcontainers
After the powder deposition the drug was loaded into the
polymer-ﬁlled microdevices by means of supercritical carbon
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Fig. 2. Schematic of the high pressure plant. Fi and Vi indicate 0.5 m ﬁlters and on/off valves.
dioxide impregnation. Fig. 2 depicts a schematic of the high pres-
sure setup used in the impregnation experiments. The operation
was performed in a 100 mL  reactor (KM 20-05 autoclave NWA,
Germany) equipped with a magnetic stirrer drive (Mrk MINI 100)
assembled in a sealed housing directly threading into the reactor
head. During the impregnation experiments the reactor was fed
with liquid CO2 through an on/off valve (V1) by a high pressure
pump (PM-101NWA, NWA, Germany). At the end of the exper-
iments the reactor was slowly emptied through an on/off purge
valve followed by a lamination valve (V2) and the outlet stream
was connected to a deﬂux ﬂask were the gaseous CO2 was  bub-
bled through an ethanol solution (95%). Finally, the drug free-CO2
stream was connected to a ﬂowmeter (SIM Brunt, Italy).
The impregnation experiments were carried out in batch condi-
tions with deﬁned steady-state values of CO2 pressure, temperature
and stirring velocity. In each experiment, weighted amounts of
crystalline ketoprofen powder and one chip were placed in sep-
arate compartments of a sample carrier placed at the bottom of
the reactor. In order to avoid damage to the microcontainers dur-
ing the chamber ﬁlling with the supercritical ﬂuid, the back of the
chips were glued onto the sample carrier with a carbon tape pad.
The reactor was then sealed and heated to the deﬁned tempera-
ture. When the set point temperature was achieved, the inlet valve
was gradually opened and the chamber was slowly ﬁlled with CO2,
in order to maintain isothermal conditions and avoid turbulence
within the reactor, which could result in detachment of the chip and
damaging of the microcontainers. When the desired pressure was
achieved, the inlet valve was closed and the stirrer was  switched
on. During the experiment the supercritical CO2 phase dissolved
the solid drug powder and swelled the polymer within the micro-
containers. The drug was therefore physically conveyed and loaded
in the polymer matrices. The impregnations were carried out at a
ﬂuid pressure of 100 and 200 bar, temperatures of 40, 50 and 60 ◦C
and durations of 1 and 4 h with a stirring velocity of 20 rpm.
In the experiments run at 100 bar the amount of drug placed
in the chamber was selected to initially achieve complete disso-
lution in supercritical CO2 and saturation conditions according to
the solubility values of ketoprofen reported by Macnaughton et al.
[16] at the chosen temperature. In this group of experiments the
temperature and time were modiﬁed from batch to batch. Because
of the batch conditions, the drug concentration could not be kept
at saturation value over time. In contrast, in the tests performed
at 200 bar a ﬁxed amount of ketoprofen was weighted and dis-
solved, based on the amount to reach saturation concentration for
the compound at 200 bar and 40 ◦C. As a consequence, at 200 bar
and 50 ◦C and 60 ◦C operation will be below saturation conditions,
as the solubility values are higher at these temperatures. In the
experiment performed at 200 bar, the exclusive effect of temper-
ature and time on the microcontainer impregnation was studied.
At the end of the experiment the reactor was depressurized at a
controlled rate for approximately 2 and 3 h when the operating
pressures were 100 and 200 bar respectively. After the experiments
the chips were stored in a desiccator until further analysis were
Table 1
Weighted mass of ketoprofen [mg] dissolved at different experimental conditions.
Pressure [bar] Temperature [◦C]
40 50 60
100 4.83 2.15 1.31
200  14.1 14.1 14.1
performed. In Table 1 the operating conditions of the experiments
are shown.
2.3. Characterization methods
2.3.1. X-ray microtomography (XCT)
For the XCT measurements a Skyscan 1172/F instrument
(Skyscan, Kontich, Belgium, control software v1.5.13) was used. A
source voltage of 60 kV and current of 165 A were used together
with a 0.5 mm thick Al ﬁlter to attenuate the high energy X-rays. For
each sample 780 shadow images were acquired over 180◦ of rota-
tion. The resulting data acquisition time was  4 h for each sample.
Reconstruction of the cross-section images was performed using
the program NRecon + GPUReconServer (Skyscan, beta v1.6.5) on a
single PC using GPU accelerated reconstruction (Windows 7 64-bit
workstation, 2 Intel Xeon X5647 with 4 cores each, 48 GB RAM,
NVIDIA quadro 4000 with 256 cores). Image reconstruction using
the Feldkamp algorithm [17] for cone beam geometry took about
30 min  per sample and resulted in, depending on sample size, about
1450 slices of 2864 × 2876 pixels each (5.2 m isotropic voxel size).
Using the DataViewer (Skycan, v1.4.4) the tablet was rotated to
align the microwells parallel to the x-axis.
2.3.2. Scanning electron microscopy (SEM)
The morphology of the impregnated microcontainers was
examined using SEM. The investigations were carried out using a
Nova600 NanoSEM from FEI (Eindhoven, the Netherlands). Imag-
ing was  performed in low-vacuum-mode at a pressure of 0.6 mbar
and an operation voltage of 5 kV. Prior to examination, the samples
were mounted onto metal stubs and were tilted by approx. 30◦.
2.3.3. Raman spectroscopy
As described in a previous study [13], Raman spectroscopy can
be used to elucidate the presence of chemical interactions amongst
drug molecules and between drug and polymer. The spectra from
the impregnated microcontainers were collected using a Thermo
Scientiﬁc Raman DXR microscope equipped with a frequency-
stabilized single mode diode laser. The Raman signal collection time
was 5 s and the signal was  averaged three times, using a 25 m slit
and a 1.0 m diameter laser post. The Raman DXR microscope was
coupled to a single grating spectrometer with a 5 cm−1 FWHM (full
width half maximum) spectral resolution and a ±2 cm−1 wavenum-
ber accuracy. All Raman spectra were recorded at a laser power of
10 mW,  using a 10× objective lens and a laser excitation wave-
length of 780 nm.  In each sample 5 containers, located at different
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Fig. 3. Optical macro images of microcontainers ﬁlled with PVP powder by manual compaction: (a) detail of the chip corner, (b) arrays in the middle of the chip.
positions on the chip, were selected and analyzed. The intrinsic
ﬂuorescence background was ﬁtted to a polynomial function and
subtracted from the collected signal.
2.3.4. In vitro drug dissolution studies
The loading of ketoprofen was determined by in vitro dissolu-
tion tests of impregnated microcontainers in 10 mL  DI water at
37 ◦C using a UV spectrophotometer DISS proﬁler (Pion, USA).
Individual chips were glued with carbon pads on teﬂon-coated
magnets which stirred at 100 rpm. For the detection of ketoprofen,
the wavelength was set to 259 nm.  After dissolution, the microcon-
tainers were observed with an optical microscope (Zeiss, Germany,
10× magnitude) to conﬁrm complete emptying. The amount of
drug loaded per chip was estimated by the ﬁnal concentration
measured in the dissolution test at 16 h. Solubility of ketopro-
fen at 37 ◦C in aqueous solutions changes signiﬁcantly with pH
between 1 and 7 [14]. However, even in the test with the high-
est drug loading, the pH of the dissolution medium drop below
5.5 as ketoprofen is a weak acid (pKa 4.5). Therefore, according to
solubility data reported in the literature [14], the dissolution tests
were performed in conditions below saturation that is without drug
precipitation, which was also conﬁrmed by the non-decreasing
monotonic trend of the drug dissolution proﬁles (data not
shown).
3. Results and discussion
3.1. Polymer ﬁlling of microcontainers and X-ray
microtomography
A picture of arrays of microcontainers ﬁlled with PVP powder is
shown in Fig. 3. The powder ﬁlling required few seconds to be per-
formed and resulted in an accurate deposition inside the cylindrical
cavities of the microwells, with minimal residues in between, as
representatively illustrated by the high color contrast between the
dark silicon surface and the brilliant white of PVP powder. In Fig. 4
a scanning electron microscopy image of microcontainers ﬁlled
with PVP powder is reported. The polymer granules are compacted
inside the microwells and this conﬁnement prevents them from
being removed by the air ﬂow which is used to remove the loose
powder in between containers after the ﬁlling step. Fig. 5 shows the
cross-sections that were reconstructed from the microtomography
data of the XCT measurements. Using this technique it is possible
to measure the internal microstructure of the PVP powder within
the containers and to visualize the effect of the impregnation on the
particle morphology. The images clearly show that the microcon-
tainers are ﬁlled with discrete PVP particles which subsequently
coalesce in bigger clusters following supercritical impregnation
with ketoprofen at 200 bar, 40 ◦C and 1 h for the example in
Fig. 5.
Fig. 4. SEM images of microcontainers ﬁlled with poly(vinylpyrrolidone) before
treatment with supercritical CO2. The scalebar indicates 300 m.
3.2. Scanning electron microscopy of impregnated
microcontainers
After the supercritical treatment, the microcontainers were ana-
lyzed by scanning electron microscopy to observe the effects of the
impregnation on the polymer morphology. As shown previously
[13], the SEM micrographs (see Fig. 6) conﬁrm that scCO2 does
not visible effects on the epoxy resin SU-8 used to fabricate the
microcontainers, which maintain their size, the cylindrical shape
and the adhesion to the silicon substrate. The supercritical ﬂuid
has instead a much more pronounced effect on PVP. At all the
tested conditions, the morphology of PVP radically changes as the
polymer particles undergo swelling and subsequent coalescence
as conﬁrmed by the XCT images (Fig. 5b). By comparing the SEM
micrographs of microcontainers treated at different pressures it is
clear that the volume of the polymer visibly increases with increas-
ing CO2 pressure. This might be also due to the presence of higher
drug amounts loaded in the polymer matrix. This can be explained
by an increase of CO2 uptake in PVP with pressure, in accordance
with what was  previously reported by Kikic and co-workers [18].
At high pressures, CO2 has a well-known plasticizing effect on cer-
tain polymers [19,20]. The plasticization leads to a drop of the Tg
from 120 to 128 ◦C for PVP [21] to a temperature close to the operat-
ing temperature during impregnation. As a result, the polymer gets
close to the glass-rubber transition. The increase of impregnation
time in general leads to a higher extent of swelling of the matrix
and to the appearance of holes. At 40 ◦C and 50 ◦C these holes got
larger when the pressure was  set at 200 bar, and this fact can be
attributed to the release of CO2 from the highly swollen matrices
upon depressurization. At 200 bar and 50 ◦C small spots appear on
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Fig. 5. Cross-sections non-destructively acquired by XCT through the microcontainers ﬁlled with poly(vinylpyrrolidone) before (a) and after impregnation with ketoprofen
by  supercritical CO2 (200 bar, 40 ◦C, 1 h) (b). The original gray scale images are shown together with a binary threshold image to highlight the change in polymer morphology.
the polymer surface. At 200 bar and 60 ◦C these particles clustered
in larger aggregates (see Fig. 6k and l) on a small number of con-
tainers on the chip. As scCO2 acts as a plasticizer for polymers the
viscosity of the CO2 saturated matrix decreases during impregna-
tion in some cases causing spillages from the containers. This aspect
is more pronounced during longer experiments.
3.3. Loading of ketoprofen into polymer ﬁlled-microcontainers
The solubility of ketoprofen in scCO2 monotonically increases
with the ﬂuid density, and therefore with the ﬂuid pressure at
isothermal conditions [16]. Furthermore, for many active com-
pounds under isobaric conditions the temperature inﬂuences the
solubility according to the operating pressure and with respect
to the crossover pressures. At the crossover points solubility
isotherms overturn their trend [16]. The upper crossover pres-
sure of ketoprofen in carbon dioxide was measured between 160
and 180 bar [18,22]. Below this pressure, such as at 100 bar, the
drug solubility decreases with temperature. At higher pressures,
such as at 200 bar, the effect of temperature is the opposite. The
impregnation pressures were chosen at a value below and above
the upper crossover point in order to explore the inﬂuence/effect
of the supercritical phase on the drug loading. In Fig. 7 the result-
ing weight fraction of ketoprofen (ωketo) respect to drug + polymer
mass, loaded in a chip containing 625 PVP ﬁlled-microcontainers is
compared for the different impregnation conditions. In Table 2 the
overall drug loading results are shown.
Despite the simplicity of the method the overall accuracy of the
loading is similar to the one previously reported where the polymer
was deposited by inkjet printing [12].
In the tests carried out at 100 bar (Fig. 7a) the drug was dissolved
in saturation conditions. Here the loading is strongly dependent on
the drug concentration in the supercritical phase, which was  higher
at 40 ◦C and lower at 60 ◦C. There is an increase in drug loading
over time for any tested temperature meaning that after 1 h the
equilibrium is not yet attained. After 4 h the drug weight fraction is
approximately doubled at all temperatures. To investigate the par-
tition equilibrium of the drug between the CO2 and the polymer
phases an impregnation experiment was  carried out at 100 bar and
40 ◦C for 24 h. The attained drug fraction was  0.27, which is very
Fig. 6. Scanning electron microscopy images of polymer ﬁlled microcontainers impregnated with ketoprofen by supercritical CO2 at different pressure, temperature and
time.  The scalebars indicate 300 m.
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Fig. 7. Mass fraction of ketoprofen (ωketo) impregnated in polymer ﬁlled 625 microcontainers at different temperatures and times: (a) at 100 bar in saturation conditions (b)
at  200 bar with a ﬁxed amount of drug dissolved in scCO2 (N = 3).
Table 2
Drug loading of impregnated microcontainers. The drug weight refers to total loaded mass on individual chips (625 microcontainers) and is normalized with respect to the
polymer mass in the microwells (N = 3).
T (◦C) P (bar) Time (h) Loaded drug per chip (mg) Drug weight fraction (keto/(PVP + keto))
40
100
1 0.33 ± 0.09 0.15 ± 0.03
4  0.58 ± 0.02 0.26 ± 0.02
100  24 0.49 0.27
200
1  0.53 ± 0.07 0.23 ± 0.03
4  0.58 ± 0.01 0.27 ± 0.03
50
100
1  0.19 ± 0.02 0.10 ± 0.01
4  0.40 ± 0.04 0.18 ± 0.02
200
1  0.55 ± 0.03 0.26 ± 0.01
4  0.71 ± 0.04 0.27 ± 0.03
60
100
1  0.08 ± 0.03 0.04 ± 0.01
4  0.16 ± 0.04 0.06 ± 0.01
200
1  0.77 ± 0.06 0.26 ± 0.03
4  1.05 ± 0.03 0.33 ± 0.01
Fig. 8. Mass of ketoprofen impregnated at 200 bar in 625 microcontainers at differ-
ent temperatures and times (N = 3) as function of the CO2 density.
close to the loading achieved after 4 h. In the experiments at 200 bar,
the impregnation is enhanced compared to experiments at 100 bar
as a result of the combined effect of the higher amount of drug dis-
solved (see Table 1) and the density of the ﬂuid at this pressure.
However, at 200 bar the loading increased with the temperature
which was unexpected, since at this pressure a rise of temperature
leads to an increase of drug solubility and therefore a less favor-
able drug partition in the polymer matrix. Moreover, from 40 ◦C to
60 ◦C the ﬂuid density decreases as shown in the proﬁles in Fig. 8,
where the loaded API weights are plotted as a function of the CO2
density. These latter results can be explained by considering that
the effect of temperature on drug-scCO2 diffusivity prevails over
the reduced ﬂuid density. A temperature increase also results in
enhanced mobility of the polymer chains, which is suggested by the
visible swelling observed in Fig. 6d, h and l. In contrast to the results
at 100 bar, at 200 bar more limited loading gains were achieved
with increased impregnation time. This might be due to the prox-
imity of the drug concentration in the polymer to saturation, which
can slow down the impregnation process.
3.4. Raman spectroscopy
Another important aspect for a drug delivery device are the
API solid state properties and the stabilization of the amorphous
phase in a polymer matrix. For this purpose, Raman scattering
spectroscopy was  utilized to detect the presence of amorphous
ketoprofen and the molecular interactions with the polymer. The
supercritical impregnation of PVP ﬁlms with poorly soluble drugs
was previously investigated by vibrational spectroscopy [23–25]. In
order to elucidate the presence of drug-polymer interactions, addi-
tional Raman spectra were collected from microcontainers ﬁlled
with physical mixtures (PMs) of the polymer and drug. Physi-
cal mixtures were obtained by gentle mixing PVP and ketoprofen
powders and subsequent ﬁlling in microcontainers as previously
described [13]. Raman scattering spectra of both fresh ketopro-
fen:PVP PMs  and mixtures prepared by supercritical CO2 are shown
in Fig. 9. In the ketoprofen:PVP PM case, the Raman scattering
spectra from both compounds are added together and retain all
characteristics of isolated ketoprofen and PVP, see Fig. 9a. To
illustrate this, the inter-ring ketoprofen carbonyl [C O] stretch-
ing mode found at 1657 cm−1 is examined for different drug/PVP
ratios [26]. A previously reported by Carvalho et al. [27], a frequency
shift for this signal can be associated to the formation of H-bonds
involving the C O group between ketoprofen and PVP. In all cases
the Raman intensity of the ketoprofen C O stretching mode com-
pared to the 1602 cm−1 C–C stretching mode is I1657/I1602 > 1. The
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Fig. 9. Raman spectra of (a) physical mixtures of PVP and crystalline ketoprofen in different representative weight percentages and (b) spectra of PVP impregnated with the
same  ketoprofen weight percentages at different experimental conditions (see Table 2).
Raman vibration can be ﬁtted to two Lorentzian functions outlin-
ing modes that belong to both ketoprofen and PVP. The FWHM of
the C O stretching mode is similar to the one recorded for pure
ketoprofen shown in the bottom part of Fig. 9a. The PM result
indicates no observable intermolecular interaction between the
two compounds [13]. The 1657 cm−1 Raman mode for supercriti-
cal CO2 impregnated ketoprofen:PVP mixtures behaves differently,
i.e. the vibrational mode intensity is reduced and the FWHM is sig-
niﬁcantly increased, see Fig. 9b. In this case, the two Lorentzian
ﬁts yield essentially a single Raman peak without a clear contri-
bution from PVP and I1657/I1602 < 1 almost for all drug/PVP ratios.
Since there is no observable frequency shift, the result suggests that
this carbonyl group is not involved in the formation of hydrogen
bonds with PVP molecules. The recorded change rather indicates
rearrangement of ketoprofen molecules into a less organized amor-
phous solid state, and a similar effect was previously observed for
aged ketoprofen:PVP PM mixtures [13]. The presence of amorphous
ketoprofen was previously conﬁrmed by X-ray diffraction [13]. It
is also expected that the CO2 assisted impregnation of PVP with
ketoprofen breaks or reduces the interaction between adjacent
ketoprofen molecules and induces the formation of the hydrogen
bonds between hydroxyl groups of ketoprofen molecules and car-
bonyl groups of PVP [24].
4. Conclusions
The present study investigates the use of CO2-aided impreg-
nation to load ketoprofen into microcontainers ﬁlled with PVP
by tuning temperature, pressure, time, and drug concentration
in the ﬂuid phase. The characterization study shows that drug
loading can be controlled with high accuracy and reproducibil-
ity and the impregnated drug is in the amorphous state. At any
tested pressure there is an increase of drug loading over time for
any tested temperature meaning that after 1 hour the equilibrium
between the polymer and the CO2 phases is not yet attained. From
the tests at 100 bar it was observed that the loading is strongly
dependent on the drug concentration in the impregnating medium.
Unexpectedly, in the tests at 200 bar the loading increased with the
temperature despite the increasing drug solubility in the scCO2.
This was attributed to the predominant effect of drug diffusivity
in the polymer matrix. In contrast, at 200 bar more limited loading
gains for increasing impregnation time were obtained probably due
to drug saturation in the polymer. The Raman scattering spectra
of the impregnated matrices indicate a rearrangement of ketopro-
fen molecules into a less organized state. However, no observable
frequency shift in was  noticed for the spectral modes typically
ascribed to drug-polymer interactions, which suggests that the
drug molecule is unlikely to be involved in the formation of hydro-
gen bonds with PVP molecules.
Our results demonstrate that the combination of powder load-
ing and SCI can be used as a high throughput loading technique for
microfabricated devices for oral drug delivery.
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